Optogenetics wins the Nobel – one neuroscience breakthrough in a line of technological innovations helping scientists map and control the brain
Neuroscientific advances follow a pattern of visualizing the brain, measuring its function and then controlling it. Optogenetics may lead to a new era of medical treatment.
Optogenetics, a technique that uses light to control neuronal activity, has earned researchers the 2026 Nobel Prize in Physiology or Medicine. This breakthrough is part of a series of technological advancements that have helped neuroscientists map and control the brain, making sense of its incredible complexity.
The journey began with visualizing neurons. In the late 1800s, Santiago Ramon y Cajal painted detailed images of brain tissue, revealing the structure of individual neurons. This work, along with Camillo Golgi's silver staining technique, earned them the 1906 Nobel Prize in Physiology or Medicine.
In the 1970s, anterograde and retrograde tracing allowed researchers to map neuronal pathways, further unraveling brain connections. Today, techniques like electron microscopy and expansion microscopy provide even finer details, with AI algorithms helping to interpret the vast amount of data generated.
Magnetic resonance imaging (MRI) also played a crucial role, enabling noninvasive imaging of brain activity. The 2003 Nobel Prize in Physiology or Medicine recognized the development of MRI techniques that make functional MRI possible.
Control over neuronal activity has come a long way since the late 1980s, when Alim-Louis Benabid developed deep brain stimulation to treat Parkinson's disease. This technique, while effective, is not precise enough for most applications. However, advancements in optogenetic techniques offer a promising alternative, potentially treating a range of diseases from vision loss to Parkinson's disease.
Written by urgent.news from The Conversation's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
